Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 1.67B | 41% |
| Gross Profit | 705M | 468.5% |
| Cost of Revenue | 965M | 9% |
| Operating expense | -80M | 112.2% |
| Net Income | 364M | 828% |
| EBITDA | 750M | 357.3% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 13.3B | 3.5% |
| Total Liabilities | 6.76B | 13.6% |
| Total Equity | 6.52B | 9.8% |
| Shares Outstanding | 494M | 0% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | 162M | 19% |
| Cash from investing | 1.24B | 3869.7% |
| Cash from financing | -1.34B | 1340.9% |
EPS
Financial Highlights for Elanco Animal Health in Q3 '24
Elanco Animal Health reported a revenue of 1.67B, which is a 41% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 705M, marking a 468.5% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 965M, a -9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were -80M, showing a -112.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 364M, showing a 828% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 750M, showing a 357.3% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Elanco Animal Health with growth in revenue, gross profit, and net income.
